Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Breast Cancer (Tokyo, Japan)|April 21, 2017
Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancerHitoshi Inari, Nobuyasu Suganuma, Kae Kawachi, et al.
Nucleic Acids Research|June 18, 2010
Insights into the DNA stabilizing contributions of a bicyclic cytosine analogue: crystal structures of DNA duplexes containing 7,8-dihydropyrido [2,3-d]pyrimidin-2-oneElla Czarina Magat Juan, Satoru Shimizu, Xiao Ma, et al.
Clinical Neurology and Neurosurgery|September 3, 2014
Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literatureRyotaro Ikeguchi, Yuko Shimizu, Shigeaki Suzuki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 19, 2016
Silent Cerebral Ischemic Lesions After Catheter Ablation of Atrial Fibrillation in Patients on 5 Types of Periprocedural Oral Anticoagulation　- Predictors of Diffusion-Weighted Imaging-Positive Lesions and Follow-up Magnetic Resonance ImagingKohki Nakamura, Shigeto Naito, Takehito Sasaki, et al.
Surgical Case Reports|July 21, 2017
Non-functioning parathyroid carcinoma: a case reportNobuyasu Suganuma, Hiroyuki Iwasaki, Satoru Shimizu, et al.
BMC Cancer|March 1, 2017
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesionsHitoshi Inari, Nobuyasu Suganuma, Kae Kawachi, et al.
BMC Pharmacology & Toxicology|October 7, 2020
5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational studyReiko Matsui, Kenichi Suzuki, Tomomi Takiguchi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2019
A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanesKan Yonemori, Akihiko Shimomura, Hiroyuki Yasojima, et al.
Translational Oncology|August 6, 2019
Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination TherapyAkihiko Shimomura, Kan Yonemori, Masayuki Yoshida, et al.
Respiratory Investigation|February 13, 2021
Polymerase-chain reaction testing to prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection in Shinjuku, an epicenter in Tokyo: The Tokyo Women's Medical University modelKen Arimura, Etsuko Tagaya, Ken Kikuchi, et al.
Pageof 22